Company Filing History:
1 out of 17 
1 out of 4 Years Active: 2015
Title: Innovations by Eduardo Antonio Ferraz Coelho
Introduction
Eduardo Antonio Ferraz Coelho is a notable inventor based in Belo Horizonte, Brazil. He has made significant contributions to the field of immunology, particularly in the development of vaccines and diagnostic methods for parasitic diseases.
Latest Patents
Coelho holds 2 patents that showcase his innovative work. His latest patents include a vaccine composition and immunization method for canine visceral leishmaniasis. This recombinant vaccine contains the recombinant A2 protein and adjuvants such as saponin, monophosphoryl lipid A, or aluminum hydroxide plus CpG. This invention allows for the distinction between vaccinated and infected animals through conventional ELISA or immunofluorescence tests. Another significant patent involves a diagnostic method for leishmaniasis using ribosomal protein extract (RPE), which aids in the diagnosis of this parasitic disease.
Career Highlights
Throughout his career, Coelho has worked with esteemed institutions such as the Federal University of Minas Gerais (Universidade Federal De Minas Gerais - Ufmg) and Laboratorios Leti, S.L. His work in these organizations has contributed to advancements in medical research and vaccine development.
Collaborations
Coelho has collaborated with notable colleagues, including Ana Paula Salles Moura Fernandes and Christiane De Freitas Abrantes. These partnerships have fostered a collaborative environment that enhances research and innovation.
Conclusion
Eduardo Antonio Ferraz Coelho's contributions to vaccine development and diagnostic methods highlight his role as an influential inventor in the field of immunology. His work continues to impact the fight against parasitic diseases, showcasing the importance of innovation in healthcare.